Berman Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$8K Buy
394
+122
+45% +$2.27K ﹤0.01% 1251
2021
Q2
$4K Buy
272
+67
+33% +$1.56K ﹤0.01% 1397
2021
Q1
$4K Hold
205
﹤0.01% 1327
2020
Q4
$4K Sell
205
-49
-19% -$1.03K ﹤0.01% 1210
2020
Q3
$6K Buy
254
+49
+24% +$1.14K ﹤0.01% 961
2020
Q2
$4K Hold
205
﹤0.01% 1044
2020
Q1
$3K Buy
+205
New +$3.75K ﹤0.01% 1025
2019
Q2
Sell
-299
Closed -$7K 1495
2019
Q1
$7K Buy
+299
New +$6.82K ﹤0.01% 754

Other funds holding EXEL

Berman Capital Advisors's EXEL Position: Q3 2021 in Review

Berman Capital Advisors increased its Exelixis (EXEL) stake by 45% in Q3 2021, buying an estimated $2.27K and bringing the position to 394 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1251.

Berman Capital Advisors first reported a position in EXEL in Q1 2019 and has held it in 8 quarters since. 340 funds tracked by Wall St. Rank hold EXEL as of Q3 2021.

  • Berman Capital Advisors held 394 shares of Exelixis worth $8K as of Q3 2021.
  • Berman Capital Advisors bought 122 Exelixis shares in Q3 2021, an estimated $2.27K.
  • Exelixis made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1251 holding.
  • Berman Capital Advisors first reported a position in Exelixis in Q1 2019 and has held it in 8 quarters since.
  • 340 funds tracked by Wall St. Rank held Exelixis as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.